Navigation Links
Reportlinker Adds Top Ten World's Leading Pharmaceutical Companies
Date:11/16/2010

NEW YORK, Nov. 16, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Top Ten World's Leading Pharmaceutical Companies

http://www.reportlinker.com/p0329551/Top-Ten-World's-Leading-Pharmaceutical-Companies.html

A thought-provoking report on performance, capabilities, goals and strategies of the major competitors in the worldwide pharmaceutical market. The report is designed to provide the pharmaceutical industry executives with strategically significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report's major objectives include:

  • To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world's leading pharmaceutical companies.
  • To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis leading competitors.
  • To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
  • To complement organizations' internal competitor information gathering efforts by providing strategic analysis, data interpretation and insight.
  • To identify the least competitive market niches with significant growth potential.

  • Contains 1,200 pages and 100 tables

    SECTION I: EXECUTIVE SUMMARY

    • A 5-10 page synopsis of key sections.

    SECTION II: BUSINESS ORGANIZATION

    • History of the company's pharmaceutical business evolution,

    which is important to understanding the corporate culture,

    management mentality, and strategies.

    • Most recent M&A activity and significant organizational changes.

    • Current organizational structure.

    SECTION III: SENIOR MANAGEMENT

    • Names, titles, and background of senior managers.

    SECTION IV: FACILITIES AND EMPLOYEES

    • Major administrative, manufacturing, and R&D facilities

    in the U.S. and abroad.

    • Manufacturing practices.

    • New plants under construction.

    • U.S. and international work force size and distribution.

    SECTION V: TECHNOLOGICAL KNOW-HOW

    • Internally developed and acquired technologies,

    processes, and related capabilities.

    • Know-how in biotechnology and other pertinent fields.

    • Proprietary technologies and patent litigations.

    SECTION VI: PRODUCT PORTFOLIO ANALYSIS

    • Extensive review of major ethical, OTC, and generic drugs.

    • Most recent new drug introductions and indications.

    SECTION VII: MARKETING TACTICS

    • Sales force in the U.S., Europe, and other regions.

    • Distribution strategies.

    • Major promotional tactics.

    SECTION VIII: FINANCIAL ANALYSIS

    • The U.S. and international sales and operating profit estimates by

    division, geographic region, therapeutic category, and individual drug.

    • The five-year sales and operating profit performance.

    • AstraZeneca

    • Eli Lilly

    • GlaxoSmithKline

    • Johnson & Johnson

    • Merck

    • Novartis

    • Pfizer

    • Roche

    • Sanofi-Aventis

    • Wyeth

    SECTION IX: R&D EXPENDITURES AND

    MAJOR PROGRAMS

    • The R&D budget.

    • Research facilities and staff.

    • New technologies, drugs, and indications in development,

    including their phase and anticipated introduction dates.

    • Worldwide sales force size.

    SECTION X: COLLABORATIVE ARRANGEMENTS

    • Major joint venture, distribution, OEM, and licensing partners, both

    industrial and academic.

    • Terms of collaborative agreements and specific products involved.

    SECTION XI: STRATEGIC DIRECTION

    • Major strengths and weaknesses.

    • Business, new product development, and marketing objectives

    and strategies.

    • Anticipated acquisitions, joint ventures, and divestitures.

    LIST OF TABLESTable MO-1: World Pharmaceutical Market

    by Major Product Segment

    Table MO-2: World Ethical Pharmaceutical Market

    by Geographic Region/Country

    Table MO-3: World Ethical Pharmaceutical Market

    by Major Drug Category

    Table AZ-1: AstraZeneca Sales and Operating Profit Growth

    Table AZ-2: AstraZeneca Sales by Therapeutic Category/Business

    Table AZ-3: AstraZeneca Sales Growth by Therapeutic

    Category/Business

    Table AZ-4: AstraZeneca Sales by Major Drug/Business

    Table AZ-5: AstraZeneca Sales Growth by Major Drug/Business

    Table AZ-6: AstraZeneca Sales by Major Drug/Business and

    Geographic Region

    Table AZ-7: AstraZeneca Sales by Geographic Region and

    Country

    Table AZ-8: AstraZeneca Sales Growth by Geographic Region and

    Country

    Table BM-1: Bristol-Myers Squibb Sales and Operating Profit

    Growth

    Table BM-2: Bristol-Myers Squibb Sales by Major Division

    Table BM-3: Bristol-Myers Squibb Sales by Major Division and

    Geographic Region

    Table BM-4: Bristol-Myers Squibb Sales Growth by Major Division

    Table BM-5: Bristol-Myers Squibb Sales by Therapeutic Category

    Table BM-6: Bristol-Myers Squibb Sales by Therapeutic Category

    and Geographic Region

    Table BM-7: Bristol-Myers Squibb Sales Growth by Therapeutic

    Category

    Table BM-8: Bristol-Myers Squibb Sales by Major Drug

    Table BM-9: Bristol-Myers Squibb Sales Growth by Major Drug

    Table BM-10: Bristol-Myers Squibb Sales by Product Line

    Table BM-11: Bristol-Myers Squibb Sales Growth by Product Line

    Table BM-12: Bristol-Myers Squibb Sales by Geographic Region

    Table BM-13: Bristol-Myers Squibb Sales Growth by Geographic

    Region

    Table BM-14: Bristol-Myers Squibb Other Health Care Sales by

    Product

    Table GL-1: GlaxoSmithKline Sales by Business Segment

    Table GL-2: GlaxoSmithKline Sales Growth by Business Segment

    Table GL-3: GlaxoSmithKline Operating Profit And Margins by

    Business Segment

    Table GL-4: GlaxoSmithKline Operating Profit by Business

    Segment

    Table GL-5: GlaxoSmithKline Sales and Operating Profit Growth

    Table GL-6: GlaxoSmithKline Sales by Major Drug

    Table GL-7: GlaxoSmithKline Sales by Drug and Geographic Region

    Table GL-8: GlaxoSmithKline Sales by Therapeutic Category

    Table GL-9: GlaxoSmithKline Sales Growth by Therapeutic

    Category

    Table GL-10: GlaxoSmithKline Sales by Geographic Region and Country

    Table GL-11: GlaxoSmithKline Sales Growth by Geographic Region

    Table GL-12: GlaxoSmithKline Consumer Healthcare Sales by

    Product Line

    Table GL-13: GlaxoSmithKline Consumer Healthcare Sales Growth

    by Product Line

    Table JJ-1: Johnson & Johnson Sales by Geographic Region and

    Country

    Table JJ-2: Johnson & Johnson Sales Growth by Geographic

    Region

    Table JJ-3: Johnson & Johnson Sales by Business Segment and

    Geographic Region

    Table JJ-4: Johnson & Johnson Sales and Operating Profit Growth

    Table JJ-5: Johnson & Johnson Sales by Major Drug

    Table JJ-6: Johnson & Johnson Pharmaceutical Sales Growth by

    Major Drug

    Table JJ-7: Johnson & Johnson Consumer Segment Sales by

    Product Line

    Table JJ-8: Johnson & Johnson Consumer Segment Sales Growth

    by Product Line

    Table ME-1: Merck Sales and Operating Profit Growth

    Table ME-2: Merck Sales by Geographic Region

    Table ME-3: Merck Sales Growth by Geographic Region

    Table ME-4: Merck Sales by Therapeutic Category

    Table ME-5: Merck Sales Growth by Therapeutic Category

    Table ME-6: Merck Sales By Major Drug

    Table ME-7: Merck Sales Growth by Major Drug

    Table ME-8: Merck Sales By Major Drug and Geographic Region

    Table NO-1: Novartis Sales and Operating Profit Growth

    Table NO-2: Novartis Sales by Business Segment

    Table NO-3: Novartis Sales Growth by Business Segment

    Table NO-4: Novartis Operating Profit by Business Segment

    Table NO-5: Novartis Operating Profit Growth by Business

    Segment

    Table NO-6: Novartis Sales by Country

    Table NO-7: Novartis Sales Growth by Country

    Table NO-8: Novartis Sales by Therapeutic Category

    Table NO-9: Novartis Sales Growth by Therapeutic Category

    Table NO-10: Novartis Sales of Top 20 Drugs

    Table NO-11: Novartis Sales Growth by Major Drug

    Table PF-1: Pfizer Sales by Division

    Table PF-2: Pfizer Sales and Operating Profit Growth

    Table PF-3: Pfizer Sales by Therapeutic Category

    Table PF-4: Pfizer Sales by Major Product

    Table PF-5: Pfizer Sales Growth by Major Product

    Table PF-6: Pfizer Sales by Geographic Region

    Table PF-7: Pfizer Sales Growth by Geographic Region

    Table RO-1: Roche Sales and Operating Profit Growth

    Table RO-2: Roche Sales by Major Division

    Table RO-3: Roche Sales Growth by Business Segment

    Table RO-4: Roche Sales by Geographic Region

    Table RO-5: Roche Sales Growth by Geographic Region

    Table RO-6: Roche Sales and Operating Profit Growth

    Table RO-7: Roche Sales by Division

    Table RO-8: Roche Operating Profit by Division

    Table RO-9: Roche Operating Profit Growth by Division

    Table RO-10: Roche Sales by Therapeutic Category

    Table RO-11: Roche Sales of Top 20 Products

    Table SA-1: Sanofi-Aventis Sales and Operating Profit Growth

    Table SA-2: Sanofi-Aventis Sales by Business Segment

    Table SA-3: Sanofi-Aventis Sales Growth by Business Segment

    Table SA-4: Sanofi-Aventis Sales of Top 15 Drugs

    Table SA-5: Sanofi-Aventis Sales Growth of Top 15 Drugs

    Table SA-6: Sanofi-Aventis Sales of 15 Major Drugs and

    Geographic Region

    Table SA-7: Sanofi-Aventis Sales by Geographic Region

    Table SA-8: Sanofi-Aventis Vaccine Sales by Major Product

    Table WY-1: Wyeth Sales by Business Segment

    Table WY-2: Wyeth Sales Growth by Business Segment

    Table WY-3: Wyeth Sales and Operating Profit Growth

    Table WY-4: Wyeth Sales by Therapeutic Category

    Table WY-5: Wyeth Sales by Major Drug

    Table WY-6: Wyeth Consumer Healthcare Sales by Product

    Table WY-7: Wyeth Consumer Healthcare Sales Growth by

    Product

    Table CA-1: The Top 10 World's Leading Pharmaceutical

    Companies Sales, Rank, and Market Share

    Table CA-2: The Top 10 World's Leading Pharmaceutical

    Companies Operating Profit, Margins, and Rank

    Table CA-3: The Top 10 World's Leading Pharmaceutical

    Companies R&D Expenditures, Percent of Sales,

    and Rank

    To order this report:Pharmaceutical Industry: Top Ten World's Leading Pharmaceutical Companies

    Pharmaceutical Business News

    More  Market Research Report

    Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
    '/>"/>

    SOURCE Reportlinker
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Reportlinker Adds Top Ten Worlds Leading Life Science Intermediates Companies
    2. Reportlinker Adds Global Blood Glucose Meters and Strips Industry
    3. Reportlinker Adds Global Ambulatory & Bathroom Aids Industry
    4. Reportlinker Adds Global Insulin Pumps (External) Industry
    5. Reportlinker Adds Global Antibiotics Industry
    6. Reportlinker Adds Global Medical Specialty Bags Industry
    7. Reportlinker Adds Global Ophthalmic Instrumentation Industry
    8. Reportlinker Adds Global Nuclear Medicine Industry
    9. Reportlinker Adds U.S. Inflammatory Diseases Drug Delivery: Physician Perspective
    10. Reportlinker Adds Proteomics - Technologies, Markets and Companies
    11. Reportlinker Adds Cardiovascular Surgical Devices: The Global Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/7/2016)... 2016 According to the latest ... Market Study on Multiplex Detection Immunoassay: North America to ... global multiplex detection immunoassay market is expected to witness a CAGR ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
    (Date:12/7/2016)... 2016 The global  blood ... of USD 3.9 billion by 2024, based on ... The growth of the market is attributed to ... advancements by the market players. Demand for blood ... donation, rising awareness about transfusion-transmitted diseases, and technological ...
    (Date:12/6/2016)... 6, 2016  Alopexx Oncology, LLC announced data from ... fusion protein (immunocytokine) composed of interleukin-2 and a CD20-targeting ... on B cells as Rituxan and maintains the activities ... also involved in tumor targeting, engagement of the immune ... results of the study (abstract #95954) were presented at ...
    Breaking Medicine Technology:
    (Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any lab to secure ... data. The team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools ... need to operate in a GLP (Good Laboratory Practice) fashion. , With features designed ...
    (Date:12/7/2016)... Boston, MA (PRWEB) , ... December 07, 2016 , ... ... They are sisters and wives, brothers and fathers, from New England and around ... illness and its stigma, and are brought together in a beautiful and compelling new ...
    (Date:12/7/2016)... ... December 07, 2016 , ... Baciocco Brothers Insurance Agency, ... in the Sacramento/Folsom region, is initiating a charity event to raise support and ... Another Chance treatment center in Sacramento works to provide area teens and families ...
    (Date:12/7/2016)... ... ... A. Kevin Spann Insurance, a New York-based firm offering insurance and financial ... charity drive to raise funds that will benefit the Marine Corps League. , The ... FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans to ...
    (Date:12/7/2016)... ... 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel of ... of proceeds to two local organizations: North Chicago Animal Control and Friends and Our ... a team of authorized and trained volunteers who support rescued animals held in the ...
    Breaking Medicine News(10 mins):